Physician profile
Caryn S Baldwin
NPI 1720458490
$2,143.24
in general payments reported to CMS, 2019-2025
10 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $55.44 · 2023: $391 · 2024: $731 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $850.10 | 2021-2025 | Proclaim |
| Saluda Medical Americas, INC. | $611.07 | 2023-2024 | Evoke, Evoke Scs |
| Medtronic, INC. | $316.96 | 2023-2025 | Intellis Adaptivestim, Synchromedii |
| Jazz Pharmaceuticals INC. | $101.11 | 2025 | |
| Almatica Pharma LLC | $93.14 | 2021-2022 | |
| Pfizer INC. | $49.09 | 2024 | |
| Globus Medical, INC. | $36.30 | 2025 | Senza |
| Boston Scientific Corporation | $30.59 | 2022 | |
| Ucb, INC. | $29.69 | 2025 | Fintepla |
| Vertex Pharmaceuticals Incorporated | $25.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caryn Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.